DWM
MRNA icon

Dorchester Wealth Management’s Moderna MRNA Stock Holding History

Dorchester Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,000
Closed -$770K – 156
2021
Q3 		$770K Hold
2,000
– – 0.19% 70
2021
Q2 		$470K Sell
2,000
-100
-5% -$17.9K 0.11% 95
2021
Q1 		$275K Hold
2,100
– – 0.07% 125
2020
Q4 		$219K Buy
+2,100
New +$212K 0.06% 133

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dorchester Wealth Management's MRNA Position: Q4 2021 in Review

Dorchester Wealth Management sold out of Moderna (MRNA) in Q4 2021, closing a stake of 2,000 shares — an estimated $770K sold.

Dorchester Wealth Management first reported a position in MRNA in Q4 2020 and held it in 4 quarters. The position peaked at $770K in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Dorchester Wealth Management reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Dorchester Wealth Management sold 2,000 Moderna shares in Q4 2021, an estimated $770K.
  • Dorchester Wealth Management first reported a position in Moderna in Q4 2020 and held it in 4 quarters.
  • Dorchester Wealth Management's Moderna position peaked at $770K in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Dorchester Wealth Management's 13F filing for Q4 2021, filed 8 Feb 2022.